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Introduction {#sec001}
============

Serum uric acid (UA) in humans is the end-product of purine metabolism, and a number of studies have shown that hyperuricemia is an important risk factor for systemic inflammation \[[@pone.0151044.ref001]\], endothelial dysfunction \[[@pone.0151044.ref002]\], hypertension \[[@pone.0151044.ref003]\], impaired fasting glucose \[[@pone.0151044.ref004]\], cardiovascular disease (CVD) and CVD mortality \[[@pone.0151044.ref005]\]. Despite a strong association between serum UA level and various CVDs in humans, UA is not considered as having a pathogenetic role in these conditions, and instead, is considered to be a reactive oxygen species (ROS) scavenger, and to have strong anti-oxidant properties \[[@pone.0151044.ref006], [@pone.0151044.ref007]\].

On the other hand, skeletal muscle strength and mass decrease with age, and recently, this clinical condition, which is defined as an important component for the evaluation of sarcopenia, has been characterized by progressive loss of motor units and wasting of muscle fibers resulting in decreased muscle function \[[@pone.0151044.ref008], [@pone.0151044.ref009]\]. The molecular mechanisms leading to sarcopenia have not been completely understood; but increased oxidative damage in muscle cells that accumulates throughout one\'s lifetime represents one of the most accepted underlying pathways \[[@pone.0151044.ref010], [@pone.0151044.ref011]\]. Thus, increased UA may play an importantly protective role in counteracting the excessive production of free radicals, especially in elder persons, who are increasingly becoming a large portion of the population. Macchi et al. \[[@pone.0151044.ref012], [@pone.0151044.ref013]\] demonstrated that higher circulating levels of serum UA are prospectively associated with higher handgrip strength (HGS) in middle aged and older persons. Unfortunately, there are few studies showing the protective effect of serum UA on health status and aging phenotypes.

We hypothesized that serum UA is associated with muscle strength. To confirm this hypothesis, we investigated whether serum UA is associated with HGS, which is a useful indicator of sarcopenia \[[@pone.0151044.ref014]\], among Japanese community-dwelling elderly persons.

Materials and Methods {#sec002}
=====================

Subjects {#sec003}
--------

The present study was designed as part of the Nomura study \[[@pone.0151044.ref015], [@pone.0151044.ref016]\]. The study population aged ≥60 years was selected through a community-based annual check-up process from the Nomura health and welfare center in a rural town located in Ehime prefecture, Japan. The physical activity level of subjects (e.g., exercise habits), information on medical history, present conditions, and medications (e.g., antihypertensive, antidyslipidemic, antidiabetic, and uric acid lowering medication) were obtained by interview using a structured questionnaire. For all these individuals, overnight fasting plasma samples were made available. Participants with an estimated glomerular filtration ratio (eGFR) of \<30 ml/min/1.73 m^2^ and uric acid lowering medication that could affect uric acid were excluded. The study complies with the Declaration of Helsinki, and was approved by the ethics committee of Ehime University School of Medicine with written informed consent obtained from each subject.

Evaluation of Risk Factors {#sec004}
--------------------------

Information on demographic characteristics and risk factors was collected using clinical files. Body mass index (BMI) was calculated by dividing weight (in kilograms) by the square of the height (in meters). Smoking status was defined as the number of cigarette packs per day multiplied by the number of years smoked (pack・year), and the participants were classified into never smokers, past smokers, light smokers (\<20 pack year) and heavy smokers (≥20 pack year). Daily alcohol consumption was measured using the Japanese liquor unit in which a unit corresponds to 22.9 g of ethanol, and the participants were classified into never drinkers, occasional drinkers (\<1 unit/day), and daily drinkers (≥1 unit/day). We measured systolic blood pressure (SBP) and diastolic blood pressure (DBP) in the right upper arm of participants in the sedentary position using an automatic oscillometric blood pressure recorder while the subjects were seated after having rested for at least 5 min. Appropriate cuff bladder size was determined at each visit based on arm circumference. Triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), creatinine (Cr), and serum UA were measured during fasting. eGFR was calculated using CKD-EPI equations modified by a Japanese coefficient (eGFR~CKDEPI~): Male, Cr ≤0.9 mg/dl, 141 × (Cr/0.9) --^0.411^ × 0.993 ^age^ × 0.813; Cr \>0.9 mg/dl, 141 × (Cr/0.9) --^1.209^ × 0.993 ^age^ × 0.813; Female, Cr ≤0.7 mg/dl, 144 × (Cr/0.7) --^0.329^ × 0.993 ^age^ × 0.813; Cr \>0.7 mg/dl, 144 × (Cr/0.7) --^1.209^ × 0.993 ^age^ × 0.813 \[[@pone.0151044.ref016]\]. Chronic kidney disease (CKD) was defined as an eGFR~CKDEPI~ of \<60 ml/min/1.73 m^2^.

HGS test {#sec005}
--------

The subject holds the dynamometer in the hand to be tested, with the arm at right angles and the elbow by the side of the body. The handle of the dynamometer is adjusted if required---the base should rest on the first metacarpal (heel of palm), while the handle should rest on the four middle fingers. When ready the subject squeezes the dynamometer with maximum isometric effort, which is maintained for about 5 seconds. No other body movement is allowed \[[@pone.0151044.ref017]\]. The mean of two right and left measurements was used for analysis.

Statistical Analysis {#sec006}
--------------------

Statistical analysis was performed using IBM SPSS Statistics Version 20 (Statistical Package for Social Science Japan, Inc., Tokyo, Japan). All valuesare expressed as mean ± standard deviation (SD), unless otherwise specified. Data for TG was skewed, and log-transformed for analysis. Subjects were divided into four groups based on quartile of serum UA according to gender, and differences among the groups were analyzed by ANOVA for the continuous variables or the χ^2^ -test for the categorical variables. Multiple linear regression analysis was used to evaluate the contribution of each confounding factor for HGS. ANCOVA was performed using a general linear model approach to determine the association between the confounding factors and HGS. In these analyses, HGS was the dependent variable, the four categories of serum UA were the fixed factors, and all confounding factors in the multiple linear regression analysis were added as covariates. The interactive effect of gender and serum UA levels on HGS was evaluated using a general linear model. A *p*-value \<0.05 was considered significant.

Results {#sec007}
=======

Characteristics of subjects categorized by gender {#sec008}
-------------------------------------------------

Gender-specific characteristics of the subjects are illustrated in [Table 1](#pone.0151044.t001){ref-type="table"}. The study included 602 men aged 72 ± 7 (range, 60--95) years and 847 women aged 71 ± 6 (range, 60--90) years. HGS was 32.5 ± 7.2 kg in men and 21.1 ± 3.9 kg in women, and serum UA was 5.9 ± 1.3 in men and 4.7 ± 1.1 in women. The prevalence of physical activity was 65.6% in men and 64.9% in women (*p* = 0.780). In men, BMI, smoking status, drinking status, DBP, TG, HbA1c, prevalence of antidiabetic medication, prevalence of CKD, serum UA, and HGS were significantly higher in men, but HDL-C, LDL-C, prevalence of antidyslipidemic medication, and eGFR~CKDEPI~ were significantly lower. There were no gender differences regarding age, exercise habits, SBP, and prevalence of antihypertensive medication.

10.1371/journal.pone.0151044.t001

###### Characteristics of subjects by gender.

![](pone.0151044.t001){#pone.0151044.t001g}

                                                                                      Men                  Women              
  ----------------------------------------------------------------------------------- -------------------- ------------------ ---------
  Age (years)                                                                         72 ± 7               71 ± 6             0.095
  Body mass index (kg/m^2^)                                                           23.0 ± 2.9           22.6 ± 3.2         0.006
  Exercise habits (No = 0, Yes = 1) (%)                                               38.4                 39.4               0.702
  Smoking status[†](#t001fn002){ref-type="table-fn"} (never/past/light/heavy (%))     43.4/39.4/2.2/15.1   97.0/1.9/0.4/0.7   \<0.001
  Drinking Status[‡](#t001fn003){ref-type="table-fn"} (never/occasional/ daily (%))   25.2/23.1/51.7       72.3/22.1/5.7      \<0.001
  Systolic blood pressure (mmHg)                                                      137 ± 17             137 ± 17           0.606
  Diastolic blood pressure (mmHg)                                                     79 ± 10              77 ± 9             \<0.001
  Antihypertensive medication (No = 0, Yes = 1) (%)                                   47.0                 46.5               0.873
  Triglycerides (mg/dl)                                                               88 (66--129)         87 (66--117)       0.015
  HDL cholesterol (mg/dl)                                                             62 ± 16              68 ± 16            \<0.001
  LDL cholesterol (mg/dl)                                                             113 ± 29             125 ± 29           \<0.001
  Antidyslipidemic medication (No = 0, Yes = 1) (%)                                   13.0                 30.9               \<0.001
  Hemoglobin A 1c (%)                                                                 5.9 ± 0.8            5.8 ± 0.5          0.014
  Antidiabetic medication (No = 0, Yes = 1) (%)                                       14.5                 5.7                \<0.001
  eGFR~CKDEPI~ (ml/min/1.73 m^2^)                                                     69.7 ± 10.5          71.7 ± 9.2         \<0.001
  Chronic kidney disease[\#](#t001fn004){ref-type="table-fn"} (No = 0, Yes = 1) (%)   16.3                 10.5               0.001
  Serum uric acid (mg/dL)                                                             5.9 ± 1.3            4.7 ± 1.1          \<0.001
  Handgrip strength (kg)                                                              32.5 ± 7.2           21.1 ± 3.9         \<0.001

HDL, high-density lipoprotein; LDL, low-density lipoprotein. Data presented are mean ± standard deviation. Data for triglycerides is skewed, and is presented as median (interquartile range) values.

† Smoking status was defined as the number of cigarette packs per day multiplied by the number of years smoked (pack・year), and the participants were classified into never smokers, past smokers, light smokers (\<20 pack year) and heavy smokers (≥20 pack year).

‡ Daily alcohol consumption was measured using the Japanese liquor unit in which a unit corresponds to 22.9 g of ethanol, and the participants were classified into never drinkers, occasional drinkers (\<1 unit/day), daily drinkers (≥1 unit/day).

\# Chronic kidney disease was defined as an glomerular filtration ratio ~CKDEPI~ of \<60 ml/min/1.73 m^2^.

\* *P*-value: student's test or χ^2^ test.

### Characteristics of subjects categorized by gender and quartiles of serum UA {#sec009}

We thought that sex-specific analyses were also required because serum UA level and handgrip strength are higher in men than in women. Gender-specific characteristics of the subjects categorized by gender and quartiles of serum UA level are illustrated in [Table 2](#pone.0151044.t002){ref-type="table"} and [Table 3](#pone.0151044.t003){ref-type="table"}. In men, BMI, TG, and prevalence of CKD were significantly higher with increased serum UA, but age, HDL-C, HbA1c levels, and eGFR~CKDEPI~ were significantly lower ([Table 2](#pone.0151044.t002){ref-type="table"}). In women, BMI, presence of antihypertensive medication, TG, HbA1c, and prevalence of CKD were significantly higher, but HDL-C levels and eGFR~CKDEPI~ were significantly lower with increased serum UA ([Table 3](#pone.0151044.t003){ref-type="table"}).

10.1371/journal.pone.0151044.t002

###### Characteristics of male subjects categorized by quartiles of serum uric acid.

![](pone.0151044.t002){#pone.0151044.t002g}

  Men                                                   Serum uric acid (mg/dL),                                                                  
  ----------------------------------------------------- -------------------------- -------------------- -------------------- -------------------- ---------
  Age (years)                                           74 ± 8                     71 ± 7               71 ± 7               72 ± 7               0.002
  Body mass index (kg/m^2^)                             22.5 ± 2.8                 23.1 ± 2.9           23.1 ± 3.1           23.5 ± 2.9           0.017
  Exercise habits, N (%)                                41.8                       35.3                 36.6                 39.3                 0.654
  Smoking status (never/past/light/heavy (%))           43.6/42.4/1.8/12.1         45.6/30.9/4.4/19.1   43.5/37.9/1.2/17.4   40.7/45.7/1.4/12.1   0.170
  Drinking Status (never/occasional/ light/heavy (%))   30.3/21.2/48.5             25.0/25.0/50.0       26.7/24.8/48.4       17.9/21.4/60.7       0.196
  Systolic blood pressure (mmHg)                        139 ± 17                   136 ± 17             134 ± 17             137 ± 15             0.069
  Diastolic blood pressure (mmHg)                       79 ± 11                    78 ± 9               79 ± 9               81 ± 10              0.053
  Antihypertensive medication (%)                       47.9                       40.4                 44.1                 55.7                 0.065
  Triglycerides (mg/dl)                                 83 (63--119)               83 (66--117)         90 (69--140)         99 (73--149)         0.001
  HDL cholesterol (mg/dl)                               65 ± 19                    61 ± 16              60 ± 15              60 ± 16              0.039
  LDL cholesterol (mg/dl)                               111 ± 28                   115 ± 28             115 ± 30             112 ± 30             0.472
  Antidyslipidemic medication (%)                       12.7                       13.2                 13.7                 12.1                 0.982
  Hemoglobin A 1c (%)                                   6.1 ± 1.3                  5.7 ± 0.5            5.8 ± 0.6            5.8 ± 0.5            0.001
  Antidiabetic medication (%)                           18.8                       12.5                 11.2                 15.0                 0.225
  eGFR~CKDEPI~ (ml/min/1.73 m^2^)                       72.2 ± 8.9                 71.7 ± 10.0          69.4 ± 8.8           65.1 ± 12.7          \<0.001
  Chronic kidney disease (%)                            8.5                        14.7                 14.9                 28.6                 \<0.001

Data presented are mean ± standard deviation. Data for triglycerides is skewed, and is presented as median (interquartile range) values.

\* *P* for trend: Kruskal Wallis test or χ^2^ test.

10.1371/journal.pone.0151044.t003

###### Characteristics of female subjects categorized by quartiles of serum uric acid.

![](pone.0151044.t003){#pone.0151044.t003g}

  Women                                                 Serum uric acid (mg/dL)                                                          
  ----------------------------------------------------- ------------------------- ---------------- ------------------ ------------------ ---------
  Age (years)                                           71 ± 7                    71 ± 6           71 ± 7             73 ± 6             0.060
  Body mass index (kg/m^2^)                             21.7 ± 3.0                22.2 ± 2.9       23.2 ± 3.2         23.6 ± 3.3         \<0.001
  Exercise habits (%)                                   35.6                      43.7             37.4               41.2               0.293
  Smoking status (never/past/light/heavy (%))           97.9/1.3/0/0.9            98.2/1.4/0/0.5   96.0/2.5/1.0/0.5   95.9/2.6/0.5/1.0   0.675
  Drinking Status (never/occasional/ light/heavy (%))   73.4/21.9/4.7             77.9/17.1/5.0    70.2/25.3/4.5      66.5/24.7/8.8      0.111
  Systolic blood pressure (mmHg)                        137 ± 18                  136 ± 17         138 ± 17           139 ± 16           0.387
  Diastolic blood pressure (mmHg)                       77 ± 10                   76 ± 9           77 ± 9             77 ± 9             0.515
  Antihypertensive medication (%)                       36.9                      40.1             53.0               58.8               \<0.001
  Triglycerides (mg/dl)                                 82 (63--108)              81 (64--109)     87 (65--118)       97 (73--138)       \<0.001
  HDL cholesterol (mg/dl)                               68 ± 16                   71 ± 17          68 ± 15            64 ± 16            \<0.001
  LDL cholesterol (mg/dl)                               125 ± 29                  124 ± 29         126 ± 28           124 ± 32           0.943
  Antidyslipidemic medication (%)                       24.9                      30.6             32.3               37.1               0.054
  Hemoglobin A 1c (%)                                   5.7 ± 0.4                 5.8 ± 0.5        5.7 ± 0.4          5.9 ± 0.5          \<0.001
  Antidiabetic medication (%)                           3.4                       7.7              4.0                7.7                0.096
  eGFR~CKDEPI~                                          75.7 ± 7.0                73.3 ± 7.7       70.5 ± 8.4         66.2 ± 11.0        \<0.001
  Chronic kidney disease (%)                            2.1                       6.3              11.1               24.7               \<0.001

Data presented are mean ± standard deviation. Data for triglycerides is skewed, and is presented as median (interquartile range) values.

\* *P* for trend: Kruskal Wallis test or χ^2^ test.

### HGS of subjects categorized by gender and quartiles of serum UA {#sec010}

As shown in [Table 4](#pone.0151044.t004){ref-type="table"}, HGS increase significantly with increased serum UA levels in both genders, and in men HGS values in Quartile-2, Quartile-3, and Quartile-4 were significantly greater than those in Quartile-1, and in women HGS value in Quartile-3 and Quartile-4 were significantly greater than those in Quartile-1.

10.1371/journal.pone.0151044.t004

###### Handgrip strength of subjects categorized by gender and quartile of serum uric acid.

![](pone.0151044.t004){#pone.0151044.t004g}

                                Serum uric acid (mg/dL)                                                                                                                                                                                                                   
  ----------------------------- ------------------------- ------------------------------------------------------- ---------------------------------------------------------------------------------------------- -------------------------------------------------------- --------------------------------------------------------
    **Men N = 602**             **N = 165**               **N = 136**                                             **N = 161**                                                                                    **N = 140**                                              ***P* for trend[\*](#t004fn002){ref-type="table-fn"}**
  Mean handgrip strength (kg)   30.5 (29.4--31.7)         33.0 (31.8--34.2)[†](#t004fn003){ref-type="table-fn"}   33.6 (32.5--34.7) [‡](#t004fn004){ref-type="table-fn"}                                         33.1 (31.9--34.2) [†](#t004fn003){ref-type="table-fn"}   \<0.001
                                **0.7--4.0**              **4.1--4.7**                                            **4.8--5.4**                                                                                   **5.5--9.3**                                             
    **Women N = 847**           **N = 233**               **N = 222**                                             **N = 198**                                                                                    **N = 194**                                              ***P* for trend[\*](#t004fn002){ref-type="table-fn"}**
  Mean handgrip strength (kg)   20.4 (19.9--20.9)         20.6 (20.1--21.1)                                       22.2 (21.6--22.7) [‡](#t004fn004){ref-type="table-fn"} [\#](#t004fn005){ref-type="table-fn"}   21.4 (20.8--22.0) [†](#t004fn003){ref-type="table-fn"}   \<0.001

Mean handgrip strength was obtained by averaging the right and left handgrip strengths. Data presented was mean (95% confidence interval).

\* *P* for trend: Kruskal Wallis test.

† *P*\<0.05

‡ *P* = 0.001 vs. Quartile-1; and

\# *P*\<0.001 vs. Quartile-2 by Bonferroni.

### A relationship between various characteristics and HGS of subjects categorized by gender {#sec011}

As shown in [Fig 1](#pone.0151044.g001){ref-type="fig"}, serum UA levels were significantly correlated with HGS only in women (r = 0.112, *p* = 0.001), but not in men (r = 0.076, *p* = 062). [Table 5](#pone.0151044.t005){ref-type="table"} shows the age-adjusted relationship between participant characteristics and HGS of the subjects categorized by gender. In men, BMI, drinking status, LDL-C, and eGFR~CKDEPI~ were significantly correlated with HGS levels and in women, BMI, drinking status, DBP, presence of antidyslipidemic medication, eGFR~CKDEPI~, and serum UA were significantly correlated with HGS.

![Relationship between serum uric acid (UA) and handgrip strength (HGS) by gender.\
Solid line, men; dashed line, women. Serum UA levels were significantly correlated with HGS in men (r = 0.138, *p*\<0.001), but not in women (r = 0.071, *p* = 0.029). There was a significant interaction between gender and increased serum UA on HGS (F = 5.313, *p* = 0.021).](pone.0151044.g001){#pone.0151044.g001}

10.1371/journal.pone.0151044.t005

###### Age-adjusted relationship between various characteristics and handgrip strength categorized by gender.

![](pone.0151044.t005){#pone.0151044.t005g}

                                                  Handgrip strength   
  ----------------------------------------------- ------------------- ------------------
  Body mass index                                 0.097 (0.017)       0.140 (\<0.001)
  Exercise habits (No = 0, Yes = 1)               0.019 (0.648)       0.015 (0.673)
  Smoking status                                  0.008 (0.851)       -0.023 (0.501)
  Drinking Status                                 0.123 (0.002)       0.097 (0.005)
  Systolic blood pressure                         0.025 (0.535)       0.062 (0.070)
  Diastolic blood pressure                        0.077 (0.058)       0.112 (0.001)
  Antihypertensive medication (No = 0, Yes = 1)   0.031 (0.453)       0.017 (0.630)
  Triglycerides                                   0.036 (0.384)       0.020 (0.570)
  HDL cholesterol                                 0.068 (0.095)       -0.034 (0.324)
  LDL cholesterol                                 0.144 (\<0.001)     0.023 (0.506)
  Antidyslipidemic medication (No = 0, Yes = 1)   0.027 (0.512)       0.085 (0.013)
  Hemoglobin A 1c                                 -0.013 (0.756)      0.024 (0.493)
  Antidiabetic medication (No = 0, Yes = 1)       -0.043 (0.294)      -0.021 (0.549)
  eGFR~CKDEPI~                                    -0.139 (0.001)      -0.147 (\<0.001)
  Serum uric acid                                 0.050 (0.221)       0.157 (\<0.001)

r, Pearson's correlation coefficient.

\*Adjusted for age. Data for triglycerides was skewed and log-transformed for analysis.

### Multiple linear regression model testing the relationship between serum UA and HGS of subjects categorized by gender {#sec012}

To further investigate whether serum UA can explain HGS independent of other confounding factors, multiple linear regression analysis using HGS as an objective variable and various confounding factors as explanatory variables were performed with subjects categorized by gender ([Table 6](#pone.0151044.t006){ref-type="table"}). In men, age, drinking status, HDL-C, LDL-C, and eGFR~CKDEPI~ were independently and significantly associated with HGS, and in women, serum UA as well as age, BMI, drinking status, DBP, and eGFR~CKDEPI~ were independently and significantly associated with HGS

10.1371/journal.pone.0151044.t006

###### Multiple linear regression models testing the relationship between serum uric acid and Handgrip strength categorized by gender.

![](pone.0151044.t006){#pone.0151044.t006g}

                                Handgrip strength                                         
  ----------------------------- ------------------- ------------------ ------------------ ------------------
  Age                           -0.590 (\<0.001)    -0.619 (\<0.001)   -0.505 (\<0.001)   -0.541 (\<0.001)
  Body mass index               0.059 (0.109)       0.062 (0.069)      0.100 (0.003)      0.093 (0.004)
  Exercise habits               0.011 (0.741)       ------             0.021 (0.474)      ------
  Smoking status                0.020 (0.546)       ------             -0.025 (0.410)     ------
  Drinking Status               0.110 (0.002)       0.104 (0.002)      0.084 (0.007)      0.081 (0.008)
  Systolic blood pressure       -0.048 (0.329)      ------             -0.048 (0.322)     ------
  Diastolic blood pressure      0.066 (0.203)       ------             0.119 (0.011)      0.087 (0.005)
  Antihypertensive medication   -0.010 (0.779)      ------             -0.046 (0.165)     -0.056 (0.086)
  Triglycerides                 0.025 (0.490)       ------             -0.050 (0.153)     ------
  HDL cholesterol               0.079 (0.039)       0.071 (0.042)      -0.030 (0.390)     ------
  LDL cholesterol               0.119 (\<0.001)     0.124 (\<0.001)    0.031 (0.343)      ------
  Antidyslipidemic medication   0.031 (0.353)       ------             0.068 (0.038)      0.055 (0.075)
  Hemoglobin A 1c               0.004 (0.920)       ------             0.007 (0.845)      ------
  Antidiabetic medication       -0.028 (0.441)      ------             -0.032 (0.372)     ------
  eGFR~CKDEPI~                  -0.146 (\<0.001)    -0.142 (\<0.001)   -0.116 (0.003)     -0.117 (0.003)
  Serum uric acid               -0.019 (0.596)      ------             0.073 (0.037)      0.069 (0.044)
  R2                            0.404 (\<0.001)     0.399 (\<0.001)    0.270 (\<0.001)    0.254 (\<0.001)

β, standardized coefficient, R^2^, coefficient of determination.

\*Adjusted for all confounding factors. Data for triglycerides was skewed and log-transformed for analysis. (------) did not remain in the final model by multiple linear regression analysis.

### Age and Multivariate-adjusted HGS of subjects categorized by gender and quartiles of serum UA {#sec013}

[Table 7](#pone.0151044.t007){ref-type="table"} shows age and multivariate-adjusted HGS of men and women categorized by each quartiles of serum UA. In women, age and multivariate-adjusted HGS was significantly higher in the Quartile-3 and Quartile-4 groups of serum uric acid than in the lower groups.

10.1371/journal.pone.0151044.t007

###### Age and Multivariate-adjusted handgrip strength of subjects categorized by gender and quartile of serum uric acid.

![](pone.0151044.t007){#pone.0151044.t007g}

                                Serum uric acid (mg/dL)                                                                                                                                                                                                                     
  ----------------------------- ------------------------- ------------------- ---------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- --------------------------------------------------------
  **Men N = 602**               **N = 165**               **N = 136**         **N = 161**                                                                                    **N = 140**                                                                                    ***P* for trend[\*](#t007fn002){ref-type="table-fn"}**
  Mean handgrip strength (kg)                                                                                                                                                                                                                                               
      Age-adjusted              31.6 (30.7--32.5)         32.6 (31.6--33.6)   33.0 (32.1--33.9) [†](#t007fn003){ref-type="table-fn"}                                         32.9 (32.0--33.9) [†](#t007fn003){ref-type="table-fn"}                                         0.101
      Multivariate-adjusted     32.0 (31.1--32.9)         32.8 (31.8--33.8)   33.0 (32.1--33.9)                                                                              32.3 (31.3--33.3)                                                                              0.409
                                **0.7--4.0**              **4.1--4.7**        **4.8--5.4**                                                                                   **5.5--9.3**                                                                                   
  **Women N = 847**             **N = 233**               **N = 222**         **N = 198**                                                                                    **N = 194**                                                                                    ***P* for trend[\*](#t007fn002){ref-type="table-fn"}**
  Mean handgrip strength (kg)                                                                                                                                                                                                                                               
      Age-adjusted              20.3 (19.9--20.7)         20.5 (20.0--20.9)   22.0 (21.5--22.5) [‡](#t007fn004){ref-type="table-fn"} [\#](#t007fn006){ref-type="table-fn"}   21.7 (21.2--22.2) [‡](#t007fn004){ref-type="table-fn"} [\#](#t007fn006){ref-type="table-fn"}   \<0.001
      Multivariate-adjusted     20.6 (20.1--21.0)         20.6 (20.2--21.1)   21.9 (21.4--22.4) [‡](#t007fn004){ref-type="table-fn"} [\#](#t007fn006){ref-type="table-fn"}   21.4 (20.9--21.9) [†](#t007fn003){ref-type="table-fn"} [\$](#t007fn005){ref-type="table-fn"}   \<0.001

Multivariate-adjusted for age, body mass index, exercise habits, smoking status, drinking status, systolic blood pressure, diastolic blood pressure, antihypertensive medication, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, antidyslipidemic medication, hemoglobin A1c, antidiabetic medication, and eGFR~CKDEPI~. Data for triglycerides was skewed and log-transformed for analysis.

\**P* for trend: ANCOVA.

† *P*\<0.05

‡ *P*\<0.001 vs. Quartile-1, and

\$ *P*\<0.05

\# *P*\<0.001 vs. Quartile-2 by Bonferroni.

Discussion {#sec014}
==========

This study demonstrated that serum UA levels are positively associated with HGS after adjusting for potential confounders in Japanese adult women aged 60--90 years.

These results suggest that serum uric acid may have a protective role in aging-associated decline in muscle strength in community-dwelling elderly women. To our knowledge, few epidemiology studies have quantified the link between serum uric acid and HGS in community-dwelling Japanese elderly women

Several prospective and cross-sectional studies have found that the link between hyperuricemia and HGS has been reported. Ruggiero et al. \[[@pone.0151044.ref018]\] demonstrated that participants within the middle serum UA quintile (4.8--5.3 mg/dL) were less disabled in instrumental activities of daily living than those in the extreme serum UA quintiles among 966 elderly persons aged 65 years and older. Among 586 Japanese male employees aged 30 years and older, Huang et al. reported that muscle strength was much lower in persons with hyperuricemia than in those without hyperuricemia and serum UA levels (quartiles) showed an inverted J-shaped curve with HGS {mean and 95% CI: Quartile-1, 41.6 (40.6--42.6) kg; Quartile-2, 42.2 (41.2--43.2) kg; Quartile-3, 41.8 (40.8--42.8) kg; Quartile-4, 40.4 (39.3--41.4) kg; *P* for trend = 0.05) \[[@pone.0151044.ref019]\]. These results are cross-sectional, and suggest that keeping serum UA at an optimal level may contribute to maintaining skeletal muscle mass. The findings of Wu et al. \[[@pone.0151044.ref013]\], however, are in contrast to these. From Chinese aged 50--74 years, they also reported that HGS levels increased significantly across serum UA tertiles (26.4 ± 8.5 kg; 30.1 ± 10.5 kg; 35.0 ± 11.4 kg; *P*\<0.001), and after adjusting for potential confounders, high serum UA level remained significantly associated with high grip strength (*P* = 0.023). Also, during the 497 InCHIANTI study, for participants aged 76.0 ± 5.4 years, follow-up HGS measurements increased significantly across baseline serum UA tertiles, and after adjusting for potential confounders and analogous baseline strength measures, higher baseline serum UA levels still remained significantly associated with higher follow-up strength measurements \[[@pone.0151044.ref012]\]. In 7,544 men and women aged 40 years of age and older, increased serum UA was significantly related to sarcopenia status, and participants in the highest group of serum UA level (\>8 mg/dL) had 2.0 times the odds of manifesting sarcopenia compared to those in the lowest group (\< 6 mg/dL) (*p*\< 0.01) after adjusting for the confounders \[[@pone.0151044.ref020]\]. In our study, the association of serum UA with HGS was observed in women only. These confiicting findings are partly related to methodological differences and to participant characteristics. In addition, as serum UA revels relate with increasing numbers of or special metabolic risk factors, the effect of UA on muscle strength might become negligible. It is very interesting to note a J-shaped association of serum UA levels with CVD events \[[@pone.0151044.ref021]\] and all-cause mortality \[[@pone.0151044.ref022], [@pone.0151044.ref023]\], implying that both lower and higher serum UA levels lead to a higher risk.

We thought that sex-specific analyses were also required because at all ages, serum UA level and handgrip strength are higher in men than in women. We cannot explain the underlying mechanism that accounts for the gender difference from this study. A partial explanation for this result could be alcohol consumption, which is more likely to be higher in men, the use of antihypertensive drugs such as diuretics, which are known to increase serum UA levels \[[@pone.0151044.ref024]\], and the influence of sex hormones due to the promotion of excretion of uric acid by estrogen \[[@pone.0151044.ref025]\]. In our study, the analysis was performed after adjusting for alcohol consumption and antihypertensive medication. Effects of sex hormone require further investigation in the future. In addition, the precise mechanisms that antioxidant effects of uric acid were different between the two genders in our study are not completely understood. UA has been known to be a neuroprotective antioxidant because of its free radical scavenger activity \[[@pone.0151044.ref026], [@pone.0151044.ref027]\], and Llull et al. have demonstrated that UA might lessen greater disability after stroke more in women than in men \[[@pone.0151044.ref028]\]. Serum UA may exerts more potential antioxidant effects also on the skeletal muscle function in women than in men.

The mechanisms that lead to stronger HGS in individuals with serum UA at an optimal level remains to be clarified. A recent study \[[@pone.0151044.ref029]\] has shown that oxidative protein damage is independently associated with low HGS among older persons, suggesting that oxidative stress might contribute to the loss of muscle strength and mass. Urate crystals contribute to the inflammatory response through the release of pro-inflammatory mediators \[[@pone.0151044.ref030]\], and the risk of urate crystal formation/precipitation increases when serum UA level exceeds 6.3 mg/dL \[[@pone.0151044.ref031]\]. Serum UA may alter the proliferation/migration of nitric oxide (NO) release from human vascular cells that is mediated by the expression of C-reactive protein (CRP) \[[@pone.0151044.ref032]\]. In addition, serum UA stimulates proliferation of angiotensin II production, and oxidative stress in vascular smooth muscle cells through the tissue renin-angiotensin system \[[@pone.0151044.ref033]\]. Moreover, serum UA was associated positively with IL-6 (IL-6), CRP and TNF-α, particularly in women \[[@pone.0151044.ref034]\]. CRP, TNF-α, and IL-6, which are a prominent markers of systemic chronic inflammation, have been significantly associated with poor HGS \[[@pone.0151044.ref035], [@pone.0151044.ref036], [@pone.0151044.ref037]\]. The negative impact of high serum UA levels on muscle strength may be largely due to the serum UA-induced pro-oxidant capacity (primarily within the cell) at higher than normal levels \[[@pone.0151044.ref019]\]. In addition, serum UA reduces endothelial nitric oxide (NO) levels, which increase blood flow to skeletal muscles and enhance glucose uptake, and strongly relate to insulin action \[[@pone.0151044.ref038]\]. Serum UA, at optimal levels, is a powerful antioxidant and a scavenger of singlet oxygen and radicals \[[@pone.0151044.ref007]\]. Waring et al. \[[@pone.0151044.ref039]\] have shown the protective effect of UA on oxidative stress generated during physical activity. Given its powerful antioxidant capacity, serum UA may protect skeletal muscle function from ROS-induced protein oxidative damage.

Several limitations should be considered in this study. First, our cross-sectional study design does not eliminate potential causal relationships between serum UA and muscle function. Second, serum UA categories are based on a single assessment of blood, which may introduce a misclassification bias. Third, we could not eliminate the possible effect of medications for hypertension and dyslipidemia, and hormone replacement treatment on the present findings. Fourth. we could not eliminate the possible effects of underlying diseases (e.g., under nutrition due to various illness and healthy diet and consequently higher serum uric acid levels) on the present findings. Therefore the demographics and referral source may limit generalizability.

Conclusions {#sec015}
===========

The present study showed that serum UA is strongly associated with muscle function among Japanese community-dwelling elderly women. The underlying mechanism behind this relationship is unclear, but seems to be independent of traditional confounding factors such as age, BMI, smoking status, alcohol consumption, blood pressure, lipids, or renal function. Thus, serum UA levels in elderly women might provide an important marker for the assessment of risk as well as a therapeutic target for the modification of sarcopenia. For healthy community-dwelling elderly women, prospective population-based studies are needed to investigate the mechanisms underlying this association to determine whether intervention, such as effective lifestyle modifications and medications that control serum UA in adults, will improve muscle function.
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